|
|
| Product Name: | BS194 | | Synonyms: | BS194;(2S,3S)-3-(7-(benzylaMino)-3-isopropylpyrazolo[1,5-a]pyriMidin-5-ylaMino)butane-1,2,4-triol;1,2,4-Butanetriol, 3-[[3-(1-Methylethyl)-7-[(phenylMethyl)aMino]pyrazolo[1,5-a]pyriMidin-5-yl]aMino]-, (2S,3S)-;(2S,3S)-3-[[3-(1-Methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]-1,2,4-butanetriol;CS-2655;BS-194;BS 194;BS-194,Antitumor,breast cancer,BS 194,xenografts,CDK,Inhibitor,MCF-7,colon cancer,retinoblastoma,BS194,anti-cancer,Cyclin dependent kinase,inhibit,HCT-116 | | CAS: | 1092443-55-4 | | MF: | C20H27N5O3 | | MW: | 385.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1092443-55-4.mol |  |
| | BS194 Chemical Properties |
| Melting point | 184-186 °C(Solv: acetonitrile (75-05-8)) | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 13.54±0.20(Predicted) |
| | BS194 Usage And Synthesis |
| Description | BS-194 is as a potent, orally available inhibitor of cyclin-dependent protein kinases (CDKs) 1, 2, 7 and 9 |
| | BS194 Preparation Products And Raw materials |
|